These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

280 related items for PubMed ID: 24326983

  • 1. Prognostic value of FDG uptake in primary inoperable non-small cell lung cancer.
    Tong AN, Han SR, Yan P, Gong H, Zhao H, Yao H, Wang YM.
    Med Oncol; 2014 Jan; 31(1):780. PubMed ID: 24326983
    [Abstract] [Full Text] [Related]

  • 2. Validation of Independent Prognostic Value of Asphericity of 18F-Fluorodeoxyglucose Uptake in Non-Small-Cell Lung Cancer Patients Undergoing Treatment With Curative Intent.
    Rogasch JMM, Furth C, Chibolela C, Hofheinz F, Ochsenreither S, Rückert JC, Neudecker J, Böhmer D, von Laffert M, Amthauer H, Frost N.
    Clin Lung Cancer; 2020 May; 21(3):264-272.e6. PubMed ID: 31839531
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. Prognostic value of whole-body total lesion glycolysis at pretreatment FDG PET/CT in non-small cell lung cancer.
    Chen HH, Chiu NT, Su WC, Guo HR, Lee BF.
    Radiology; 2012 Aug; 264(2):559-66. PubMed ID: 22692034
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Prognostic value of FDG uptake in early stage non-small cell lung cancer.
    Hanin FX, Lonneux M, Cornet J, Noirhomme P, Coulon C, Distexhe J, Poncelet AJ.
    Eur J Cardiothorac Surg; 2008 May; 33(5):819-23. PubMed ID: 18374589
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Incorporation of the SUVmax Measured From FDG PET and Neutrophil-to-lymphocyte Ratio Improves Prediction of Clinical Outcomes in Patients With Locally Advanced Non-small-cell Lung Cancer.
    Guo D, Jin F, Jing W, Li M, Chen D, Zou B, Jiang G, Fu L, Zhu H, Kong L, Wu J, Yu J, Yue J.
    Clin Lung Cancer; 2019 Nov; 20(6):412-419. PubMed ID: 31300364
    [Abstract] [Full Text] [Related]

  • 14. Revisiting the prognostic value of preoperative (18)F-fluoro-2-deoxyglucose ( (18)F-FDG) positron emission tomography (PET) in early-stage (I & II) non-small cell lung cancers (NSCLC).
    Agarwal M, Brahmanday G, Bajaj SK, Ravikrishnan KP, Wong CY.
    Eur J Nucl Med Mol Imaging; 2010 Apr; 37(4):691-8. PubMed ID: 19915840
    [Abstract] [Full Text] [Related]

  • 15. Primary tumor PET/CT [¹⁸F]FDG uptake is an independent predictive factor for regional lymph node metastasis in patients with non-small cell lung cancer.
    Li M, Wu N, Zheng R, Liang Y, Liu Y, Zhang W, Li N, Zhao P.
    Cancer Imaging; 2013 Feb 07; 12(3):566-72. PubMed ID: 23399986
    [Abstract] [Full Text] [Related]

  • 16. Volume-based parameters measured by using FDG PET/CT in patients with stage I NSCLC treated with stereotactic body radiation therapy: prognostic value.
    Satoh Y, Onishi H, Nambu A, Araki T.
    Radiology; 2014 Jan 07; 270(1):275-81. PubMed ID: 24029640
    [Abstract] [Full Text] [Related]

  • 17. The increment in standardized uptake value determined using dual-phase 18F-FDG PET is a promising prognostic factor in non-small-cell lung cancer.
    Chen HH, Lee BF, Su WC, Lai YH, Chen HY, Guo HR, Yao WJ, Chiu NT.
    Eur J Nucl Med Mol Imaging; 2013 Oct 07; 40(10):1478-85. PubMed ID: 23744342
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Prognostic value of (18) F-fluoroazomycin arabinoside PET/CT in patients with advanced non-small-cell lung cancer.
    Saga T, Inubushi M, Koizumi M, Yoshikawa K, Zhang MR, Tanimoto K, Horiike A, Yanagitani N, Ohyanagi F, Nishio M.
    Cancer Sci; 2015 Nov 07; 106(11):1554-60. PubMed ID: 26292100
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 14.